The pharmaceutical industry has always been a high-stakes gamble. For every drug that reaches pharmacy shelves, thousands of molecular candidates fall by the wayside, casualties of a discovery process that devours billions of pounds and stretches across decades. The traditional odds are brutally unfavourable: roughly one in 5,000 compounds that...